Application of recombinant rhodostomin in studying cell adhesion

Journal of Biomedical Science

Volumn 4, Issue 5, 1997, Pages 235-243

  Chang, Hsin Hou ^a   Chang, Chih Pei ^a   Chang, Jui Chin ^a   Dung, Shing Zeng ^b   Lo, Szecheng J ^a,b  

^a School of Life Sciences   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bone marrow stromal cell; Disintegrin; Extracellular matrix; Integrin; Kistrin; Metastasis

Indexed keywords

DISINTEGRIN; RHODOSTOMIN; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CELL ADHESION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SEQUENCE ANALYSIS; THROMBOCYTE AGGREGATION;

EID: 0030781352     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253423     Document Type: Conference Paper

References (62)

1. Adler M, Lazarus RA, Dennis MS, Wanger G. Solution structure of kistrin, a potent platelet aggregation inhibitor of GPIIb-IIIa antagonist. Science 253:445-447;1991.
2. Agarwal KL, Buchi H, Caruthers MH, Gupta N, Khorana HG, Kleppe K, Kumar A, Ohtsuka E, Rajbhandary UL, Van de Sande JH, Sgaramella V, Weber H, Yamada T. Total synthesis of the gene for an alanine transfer ribonucleic acid from yeast. Nature 227:27-34;1970.
3. Alfandari D, Wolfsberg TG, White JM, DeSimone DW. ADAM 13: A novel ADAM expressed in somitic mesoderm and neutral crest cells during Xenopus laevis development. Dev Biol 182:314-330;1997.
4. 1 functions as a sperm receptor. Cell 81:1095-1104;1995.
5. Au LC, Chou JS, Chang KJ, Teh GW, Lin SB. Nucleotide sequence of a full-length cDNA encoding a common precursor of platelet aggregation inhibitor and haemorrhagic protein from Calloselasma rhodostoma venom. Biochim Biophys Acta 1173:243-245;1993.
6. Au LC, Huang YB, Huang TF, Teh GW, Lin HH, Choo KB. A common precursor for a putative haemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of the venom of Calloselasma rhodosoima: Molecular cloning and sequence analysis. Biochem Biophys Res Commun 181:585-593;1991.
7. Benayahu D, Kletter Y, Zipori D, Wientroub S. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol 140:1-7; 1989.
8. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumornecrosis factor-α from cells. Nature 385:729-733;1997.
9. Blobel CP, White JM. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 4:760-765;1992.
10. Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356: 248-252;1992.
11. Chang HH. Characterization of the recombinant rhodostomin induced cell adhesion and morphological change; PhD thesis, Institute of Microbiology and Immunology, School of Life Science, National Yang-Ming University, Taipei, Taiwan, 1996.
12. Chang HH, Chang Cp, Lo SJ. Cell adhesion and morphological change on plates coated with genetically engineered rhodostomin. Mol Biol Cell 7:S-244a;1996.
13. Chang HH, Hu ST, Huang TF, Chen SH, Lee YHW, Lo SJ. Rhodostomin, an RGD-containing peptide expressed from a synthetic gene in Escherichia coli, facilitates the attachment of human hepatoma cells. Biochem Biophys Res Commun 190:242-249;1993.
14. Chang HH, Tsai WJ, Lo SJ. Glutathione S-transferase-rhodostomin fusion protein inhibits platelet aggregation and induces platelet shape change. Toxicon 35:195-204;1997.
15. Chi LM, Vyas AA, Rule GS, Wu WG. Expression of glutatione S-transferase-cardiotoxin fusion protein in Escherichia coli. Toxicon 32: 1679-1683;1995.
16. Chiang HS, Swaim MW, Huang TF. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br J Haematol 87:325-331; 1994.
17. Damsky CH, Werb Z. Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information. Curr Opin Cell Biol 4:772-781;1992.
18. Dennis MS, Carter P, Lazarus RA. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis. Proteins 15:312-321;1993.
19. Fidler U. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35:218-224;1975.
20. Fiordalisi JJ, Gigowski RL, Grant GA. Purification of an active species of recombinant kappa-bungarotoxin. Protein Exp Purif 3:282-289;1992.
21. Friedenstein AJ, Gorskaja U, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 276-284;1976.
22. Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. A potent platelet aggregation inhibitor from the venom of the viper Echis carinatus. J Biol Chem 263:19827-19832;1988.
23. Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ, Niewiarowski S. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195:168-171;1990.
24. Hawrani ASEI, Moreton KM, Sessions RB, Clarke AR, Holbrook JJ. Engineering surface loops of proteins - a preferred strategy for obtaining new enzyme function. Trends Biotechnol 12:207-211;1994.
25. Huang TF, Niewiarowski S. Disintegrins: The naturally-occurring antagonists of platelet fibrinogen receptor. J Toxicol Toxin Rev 13: 253-273;1994.
26. Huang TF, Ouyang C. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb Res 33:124-138;1984.
27. Huang TF, Yeh HI, Ouyang C. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 22:243-251;1984.
28. Huang TF, Wu YJ, Ouyang C. Action mechanism of the platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta 925:248-257;1987.
29. Huovila A-P J, Almeida ACA, White JM. ADAMs and cell fusion. Curr Opin Cell Biol 8: 692-699;1996.
30. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25; 1992.
31. Jayaraman K, Puccini CJ. A PCR-mediated gene synthesis strategy involving the assembly of oligonucleotides representing only one of the strands. BioTechniques 12:392-398;1992.
32. Jent TW, Hendon RA, Fraenkel-Conrat H. Search for relationship among the hemolytic, phosphopolytic and neurotoxic activities of snake venoms. Proc Natl Acad Sci USA 75: 600-604;1978.
33. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 120:577-585;1993.
34. Kelley MJ, Crowl RM, Dennis EA. Renaturation of cobra venom phospholipase A2 expressed from a synthetic gene in Escherichia coli. Biochim Biophys Acta 1118:107-115; 1992.
35. Kini RM, Evans HJ. Effects of snake venom proteins on blood platelets (review article). Toxicon 28:1387-1422;1990.
36. Kini RM, Evans HJ. Structural domains in venom proteins: Evidence that metalloproteases and non-enzymatic platelets aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30:265-293;1992.
37. Kumar TKS, Yang PW, Lin SH,Wu CY, Lei B, Lo SJ, Tu SC, Yu C. Cloning, direct expression and purification of a snake venom cardiotoxin in Escherichia coli. Biochem Biophys Res Commun 219:450-456;1996.
38. Lazarus RA, McDowell RS. Structural and function aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa. Curr Opin Biotech 4:438-445;1993.
39. Lee CY. Chemistry and pharmacology of polypeptide toxins in snake venoms. Ann Rev Pharmacol 12:265-286;1972.
40. Lu X, Rahman S, Kakkar W, Authi KS. Substitutions of proline 42 to alanine and methionine 46 to asparagine around the RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elegantin. J Biol Chem 271:289-294; 1996.
41. Malaval L, Modrowski D, Gupta AK, Aubin JE. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555-572;1994.
42. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254:317-330;1988.
43. Moss NL, Jin S-LC, Milla ME, Burhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer JD. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature 385: 733-736;1997.
44. Nygren PA, Stahl S, Uhlen M. Engineering proteins to facilitate bioprocessing. Trends Biotechnol 12:184-188;1994.
45. Ouyang C, Huang TF. Potent platelet aggregation inhibitor from Trimersurus gramineus snake venom. Biochim Biophys Acta 757:332-341;1983.
46. Ouyang C, Ma YH, Jih HC, Teng CM. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim Biophys Acta 841:1-7;1985.
47. Ouyang C, Teng CM, Huang TF. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30:945-966;1992.
48. Ouyang C, Yeh HI, Huang TF. A potent platelet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 21:979-804;1983.
49. Potts JR, Campbell ID. Fibronectin structure and assembly. Curr Opin Cell Biol 6:648-655; 1994.
50. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74;1997.
51. 3 contains distinct and interacting binding sites for snake venom RGD (Arg-Gly-Asp) proteins. Biochem J 312:223-232;1995.
52. Ron D, Dressler H. pGSTag - a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. Biotechniques 13: 866-869;1992.
53. Russell FE. The use of venoms and venom fractions in medicine and biology. Toxicon 15: 267-269;1983.
54. Scragg MA, Ferrira LR. Evaluation of different staining procedures for the quantification of fibroblasts cultured in 96-well plates. Anal Biochem 198:80-85;1991.
55. Sheu JR, Lin CH, Chung JL, Teng CM, Huang TF. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn J Cancer Res 83:885-893;1992.
56. Sheu JR, Huang TF. Ex-vivo and in vivo antithrombotic effect of triflavin, an RGD-containing peptide. J Pharm Pharmacol 46:58-62; 1994.
57. Teng CM, Huang TF. Snake venom constituents that affect platelet function. Platelet 2:77-87;1991.
58. Weskamp G, Blobel CP. A family of cellular proteins related to snake venom disintegrins. Proc Natl Acad Sci USA 91:2748-2751;1994.
59. Weskamp G, Kratzschmar J, Reid MS, Blobel CP. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 132:717-726;1996.
60. Wolfsberg TG, Primakoff P, Myles DG, White JM. ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131:275-278;1995.
61. Ye QZ, Johnson L, Baragi V. Gene synthesis and expression in E. coli for PUMP, a human matrix metalloproteinase. Biochem Biophys Res Commun 186:143-149;1992.
62. Yuan R, Primakoff P, Myles DG. A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion. J Cell Biol 137:105-112;1997.